Condition: Glut1 Deficiency Syndrome 1 · Glucose Metabolism Disorders · Epilepsy · Sponsor: Weill Medical College of Cornell University
The goal is to develop methodology to monitor flux in the citric acid cycle in brain via 13C nuclear magnetic resonance (NMR) spectroscopy at 7 Tesla or 3 Tesla.
This description comes directly from the study's public registry record.
Juan M Pascual, M.D. · 212 746 3278 · jup9003@med.cornell.edu
Rocio Moron Ares, B.S. · 212 746 3278 · rrm4007@med.cornell.edu
Always discuss trial participation with your own doctor first.
| Weill Cornell Medicine | New York, New York, United States | Recruiting |
| UT Southwestern Medical Center | Dallas, Texas, United States | Terminated |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05085704